ConductScience.org, home

Trial · NCT03603496

Post-Discharge Smoking Cessation Strategies: Helping HAND 4

NCT03603496, Phase 4, Completed, Massachusetts General Hospital; results first posted 2022-05-05

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Post-Discharge Smoking Cessation Strategies: Helping HAND 4. Trials, record NCT03603496. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT03603496

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Post-Discharge Smoking Cessation Strategies: Helping HAND 4
NCT number
NCT03603496
Status
Completed
Phases
Phase 4
Enrollment
1,416 participants, actual
Lead sponsor
Massachusetts General Hospital
Conditions
Smoking Cessation
Interventions
Transitional Tobacco Care Management (TTCM), eReferral to State Tobacco Quitline (QL), Nicotine replacement therapy
First posted
2018-07-27
Last updated
2022-05-05
Results first posted
2022-05-05

Source ClinicalTrials.gov

Registered outcomes7

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryTobacco Abstinence, Biochemically Confirmed6 months after hospital discharge
Participant self-report of no use of any tobacco product (cigarettes, cigars, little cigars, pipes, smokeless tobacco product) in the past 7 days AND either a saliva sample with a cotinine concentration \<=10 ng/ml OR breath sample with a carbon monoxide concentration \<=9 ppm.
SecondaryTobacco Abstinence, Self-report1 month after hospital dischargeParticipant self-report of abstinence for the past 7 days from any tobacco product use (cigarettes, cigars, little cigars, pipes, smokeless tobacco product).
SecondaryTobacco Abstinence, Self-report3 months after hospital dischargeParticipant self-report of abstinence for the past 7 days from any tobacco product use (cigarettes, cigars, little cigars, pipes, smokeless tobacco product).
SecondaryTobacco Abstinence, Self-report6 months after hospital dischargeParticipant self-report of abstinence for the past 7 days from any tobacco product use (cigarettes, cigars, little cigars, pipes, smokeless tobacco product).
SecondaryEngagement in Cessation Treatment1 month after hospital dischargeNumber of participants who report currently using tobacco treatment (defined as cessation medication or cessation counseling) at the 1 month post-discharge assessment.
SecondaryEngagement in Cessation Treatment3 months after hospital dischargeNumber of participants who report currently using tobacco treatment (defined as cessation medication or cessation counseling) at 3 month post-discharge assessment
SecondarySelf-reported Continuous Tobacco Abstinence Since Hospital Discharge6 months follow-upNumber of participants who self-report having smoked no cigarettes and used no other tobacco products (cigars, little cigars, pipes, smokeless tobacco) since index hospital discharge

Outcomes7

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured as
PRIMARYTobacco Abstinence, Biochemically Confirmed6 months after hospital dischargeParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYTobacco Abstinence, Self-report1 month after hospital dischargeParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYTobacco Abstinence, Self-report3 months after hospital dischargeParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYTobacco Abstinence, Self-report6 months after hospital dischargeParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYEngagement in Cessation Treatment1 month after hospital dischargeParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYEngagement in Cessation Treatment3 months after hospital dischargeParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYSelf-reported Continuous Tobacco Abstinence Since Hospital Discharge6 months follow-upParticipantsCOUNT_OF_PARTICIPANTS

Results by group14

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Tobacco Abstinence, Biochemically ConfirmedTransitional Tobacco Care Management (TTCM)110Participants
Tobacco Abstinence, Biochemically ConfirmedeReferral to State Tobacco Quitline (QL)96Participants
Tobacco Abstinence, Self-reportTransitional Tobacco Care Management (TTCM)291Participants
Tobacco Abstinence, Self-reporteReferral to State Tobacco Quitline (QL)246Participants
Tobacco Abstinence, Self-reportTransitional Tobacco Care Management (TTCM)276Participants
Tobacco Abstinence, Self-reporteReferral to State Tobacco Quitline (QL)218Participants
Tobacco Abstinence, Self-reportTransitional Tobacco Care Management (TTCM)234Participants
Tobacco Abstinence, Self-reporteReferral to State Tobacco Quitline (QL)202Participants
Engagement in Cessation TreatmentTransitional Tobacco Care Management (TTCM)489Participants
Engagement in Cessation TreatmenteReferral to State Tobacco Quitline (QL)369Participants

Participant flow6

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits counted
Overall StudySTARTEDTransitional Tobacco Care Management (TTCM)706
Overall StudySTARTEDeReferral to State Tobacco Quitline (QL)703
Overall StudyCOMPLETEDTransitional Tobacco Care Management (TTCM)520
Overall StudyCOMPLETEDeReferral to State Tobacco Quitline (QL)518
Overall StudyNOT COMPLETEDTransitional Tobacco Care Management (TTCM)186
Overall StudyNOT COMPLETEDeReferral to State Tobacco Quitline (QL)185

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals6

The totals the trial posted for each group.

TotalGroupAffectedAt risk
Total, all-cause mortalityTransitional Tobacco Care Management (TTCM)19706
Total, all-cause mortalityeReferral to State Tobacco Quitline (QL)24703
Total, other adverse eventsTransitional Tobacco Care Management (TTCM)00
Total, other adverse eventseReferral to State Tobacco Quitline (QL)00
Total, serious adverse eventsTransitional Tobacco Care Management (TTCM)00
Total, serious adverse eventseReferral to State Tobacco Quitline (QL)00

Papers3

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
32299470DERIVEDPubMed
35759282DERIVEDPubMed
37209421DERIVEDPubMed

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons8

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

ComparisonSource
Transitional Tobacco Care Management (TTCM) vs eReferral to State Tobacco Quitline (QL): Tobacco Abstinence, Self-reportTrial comparisons
Transitional Tobacco Care Management (TTCM) vs eReferral to State Tobacco Quitline (QL): Engagement in Cessation TreatmentTrial comparisons
Transitional Tobacco Care Management (TTCM) vs eReferral to State Tobacco Quitline (QL): Tobacco Abstinence, Self-reportTrial comparisons
Transitional Tobacco Care Management (TTCM) vs eReferral to State Tobacco Quitline (QL): Tobacco Abstinence, Self-reportTrial comparisons
Transitional Tobacco Care Management (TTCM) vs eReferral to State Tobacco Quitline (QL): Engagement in Cessation TreatmentTrial comparisons
Transitional Tobacco Care Management (TTCM) vs eReferral to State Tobacco Quitline (QL): Self-reported Continuous Tobacco Abstinence Since Hospital DischargeTrial comparisons
Transitional Tobacco Care Management (TTCM) vs eReferral to State Tobacco Quitline (QL): Tobacco Abstinence, Biochemically ConfirmedTrial comparisons
Transitional Tobacco Care Management (TTCM) vs eReferral to State Tobacco Quitline (QL): deaths from any causeTrial comparisons

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT03603496

GET https://conductscience.org/api/trials/v1/NCT03603496/registered